From the Journals

COVID-19 antibody response not reduced with diabetes

Publish date: October 20, 2020

 

A version of this article originally appeared on Medscape.com.

Pages

Recommended Reading

Half of type 1 diabetes patients with COVID-19 manage at home
MDedge Psychiatry
For COVID-19 plus diabetes, glycemic control tops treatment list
MDedge Psychiatry
Daily Recap: FDA revokes emergency use of hydroxychloroquine; Hardest hit specialties ranked in financial report
MDedge Psychiatry
Cognitive deficits complex in youths with type 2 diabetes
MDedge Psychiatry
Daily Recap: Lifestyle vs. genes in breast cancer showdown; Big pharma sues over insulin affordability law
MDedge Psychiatry
Good for profits, good for patients: A new form of medical visits
MDedge Psychiatry
COVID-19 taking financial toll on people in U.S. with diabetes
MDedge Psychiatry
Does metformin reduce risk for death in COVID-19?
MDedge Psychiatry
Vascular dementia risk particularly high in type 2 diabetes
MDedge Psychiatry
Smart health devices – promises and pitfalls
MDedge Psychiatry